Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4206834
Max Phase: Preclinical
Molecular Formula: C48H66N8O5
Molecular Weight: 835.11
Molecule Type: Small molecule
Associated Items:
ID: ALA4206834
Max Phase: Preclinical
Molecular Formula: C48H66N8O5
Molecular Weight: 835.11
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)[C@H](NC(=O)[C@@H]1CCCN1C(=O)c1ccccc1)C(=O)N[C@@H](CN)C(=O)N[C@@H](CC1CCCC1)C(=O)N1CCC[C@H]1c1nc(-c2ccccc2)cn1CC1CCCCC1
Standard InChI: InChI=1S/C48H66N8O5/c1-32(2)42(53-45(58)41-25-15-27-56(41)47(60)36-22-10-5-11-23-36)46(59)52-38(29-49)44(57)51-37(28-33-16-12-13-17-33)48(61)55-26-14-24-40(55)43-50-39(35-20-8-4-9-21-35)31-54(43)30-34-18-6-3-7-19-34/h4-5,8-11,20-23,31-34,37-38,40-42H,3,6-7,12-19,24-30,49H2,1-2H3,(H,51,57)(H,52,59)(H,53,58)/t37-,38-,40-,41-,42-/m0/s1
Standard InChI Key: TYQWCNJKLRSFCK-PKXSCIEESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 835.11 | Molecular Weight (Monoisotopic): 834.5156 | AlogP: 5.75 | #Rotatable Bonds: 16 |
Polar Surface Area: 171.76 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 4 |
#RO5 Violations: 2 | HBA (Lipinski): 13 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.77 | CX Basic pKa: 8.09 | CX LogP: 5.48 | CX LogD: 4.71 |
Aromatic Rings: 3 | Heavy Atoms: 61 | QED Weighted: 0.14 | Np Likeness Score: -0.58 |
1. Du L, Grigsby SM, Yao A, Chang Y, Johnson G, Sun H, Nikolovska-Coleska Z.. (2018) Peptidomimetics for Targeting Protein-Protein Interactions between DOT1L and MLL Oncofusion Proteins AF9 and ENL., 9 (9): [PMID:30258537] [10.1021/acsmedchemlett.8b00175] |
Source(1):